BellaSeno trials next generation breast implant technology

The MTPConnect Podcast

Το περιεχόμενο παρέχεται από το MTPConnect. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον MTPConnect ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.

1+ y ago 38:37

MP3•Αρχική οθόνη επεισοδίου

BellaSeno is a clinical-stage medical device company born in Queensland in 2015 and now expanded to Liepzig in Germany. They are developing a next generation fully resorbable breast implant for soft tissue reconstruction, which recently started clinical trials in Australia.

We connect with BellaSeno’s Co-Founder & Chief Executive Officer Dr Mohit Chhaya and Chief Medical Officer Dr Tobias Grossner in Germany, to discuss their ground-breaking 3D printing technology that aims to restore breast tissue. In a global collaboration, their team has been working with Queensland’s Herston Biofabrication Institute.
And Brisbane breast surgeon and Director of the Comprehensive Breast Cancer Institute, Professor Owen Ung, shares a clinicians view on the importance of this innovation for patients. Professor Ung is a principal investigator for a trial which began recently in Queensland.
MTPConnect hosts are Caroline Duell, Director Media and Communications and Andrew Bowskill, Director of Stakeholder Engagement for Queensland.

186 επεισόδια

#Science #Tech #Fitness #Medicine #MTPConnect #Health and Well-Being #Medtech #Pharma #Industries